Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 225-245-2 | CAS number: 4736-60-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Negative in reverse gene mutation assay in bacteria (Salmonella typhimurium TA 98, TA 100, TA 1535, TA 1537 and TA 102 with and without metabolic acitvation, OECD 471/EU B.13/14, GLP)
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017-04-21 to 2017-05-19
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 21st July, 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- May 30, 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Version / remarks:
- August, 1998
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his operon
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9 mix
- Test concentrations with justification for top dose:
- Experiment I:
3.16, 10.0, 31.6, 100, 316, 1000, 2500 and 5000 μg/plate
Experiment II:
1.00, 3.16, 10.0, 31.6, 100, 316, 1000 and 2500 μg/plate
based on the results of a preliminary test. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The vehicle was diluted prior to the experiment and the solvent was compatible with the survival of the bacteria and the S9 activity. - Untreated negative controls:
- yes
- Remarks:
- A.dest.
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-o-phenylene-diamine (without metabolic activation, strains TA 98, TA1537), 2-aminoanthracene (with metabolic activation, strains TA 98, TA 100, TA 1535, TA 1537 and TA 102)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation) and preincubation method
DURATION
- Preincubation period: 60 min at 37°C
- Exposure duration: 48 h at 37°C
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: other: Cytotoxicity can be detected by a clearing or rather diminution of the background lawn or a reduction in the number of revertants down to a mutation factor of approximately ± 0.5 in relation to the solvent control. - Rationale for test conditions:
- The test was performed as recommended in the respective guidelines.
- Evaluation criteria:
- The Mutation Factor is calculated by dividing the mean value of the revertant counts by the mean values of the solvent control (the exact and not the rounded values are used for calculation).
A test item is considered as mutagenic if:
- a clear and dose-related increase in the number of revertants occurs and/or
- a biologically relevant positive response for at least one of the dose groups occurs
in at least one tester strain with or without metabolic activation.
A biologically relevant increase is described as follows:
- if in tester strains TA 98, TA 100 and TA 102 the number of reversions is at least twice as high
- if in tester strains TA 1535 and TA 1537 the number of reversions is at least three times higher
than the reversion rate of the solvent control. - Key result
- Species / strain:
- other: TA 98, 100, 102, 1535, 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: No precipitation of the test item was observed in any tester strain used in experiment I and II (with and without metabolic activation).
RANGE-FINDING/SCREENING STUDIES: Preliminary study performed with 3.16, 10.0, 31.6, 100,316, 1000, 2500 and 5000 µg/plate test substance
CYTOTOXICITY: Toxic effects of the test item were noted in all tester strains evaluated in experiment I and II.
In experiment I toxic effects of the test item were observed in tester strains TA 98, TA 1535 and TA 102 at concentrations of 1000 μg/plate and higher (without metabolic activation) and at concentrations of 2500 μg/plate and higher (with metabolic activation). In tester strain TA 100 toxic effects of the test item were noted at concentrations of 316 μg/plate and higher (without metabolic activation) and at concentrations of 1000 μg/plate (with metabolic activation). In tester strain TA 1537 toxic effects of the test item were observed at concentrations of 1000 μg/plate and higher (with and without metabolic activation).
In experiment II toxic effects of the test item were noted in tester strain TA 98 at concentrations of 1000 μg/plate and higher (without metabolic activation) and at concentrations of 316 μg/plate and higher (with metabolic activation). In tester strain TA 100 toxic effects of the test item were noted at concentrations of 316 μg/plate and higher (without metabolic activation) and at concentrations of 1000 μg/plate and higher (with metabolic activation). In tester strain TA 1535 toxic effects of the test item were observed at concentrations of 1000 μg/plate and higher (with and without metabolic activation). In tester strain TA 1537 toxic effects of the test item were noted at concentrations of 100 μg/plate and higher (without metabolic activation) and at concentrations of 316 μg/plate and higher (with metabolic activation). In tester strain TA 102 toxic effects of the test item were noted at concentrations of 100 μg/plate and higher (without metabolic activation) and at concentrations of 1000 μg/plate and higher (with metabolic activation).
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data:
Historical Laboratory Control Data of the Positive Control (in 2014 - 2016) without S9 ( - S9)
TA 99 TA 100 TA 1535 TA 1537 TA 102
Substance 4-NOPD NaN3 NaN3 4-NOPD MMS
Canc./plate 10µg 10µg 10µg 40µg 1µg
Mean 430.7 612.1 792.0 94.5 1729.2
SD 155.5 220.0 299.5 22.7 518.8
Min 141 132 38 35 272
Max 1830 1423 1854 273 3321
RSD [%] 36.1 35.9 37.8 24.0 30.0
n 971 1188 931 929 682
Historical Laboratory Control Data of the Positive Control (in 2014 - 2016) with S9 ( - S9)
TA 98 TA 100 TA 1535 TA 1537 TA 102
Substance 2-AA 2-AA 2-AA 2-AA 2-AA
Canc./plate 2.5 µg 2.5 µg 2.5 µg 2.5 µg 10 µg
Mean 1880.5 1727.7 133.9 234.1 801.2
SD 708.5 522.0 134.9 101.4 223.7
Min 70 169 22 26 137
Max 3606 3132 1954 682 3588
RSD [%] 37.7 30.2 100.8 43.3 27.9
n 966 1184 927 925 678
- Negative (solvent/vehicle) historical control data:
Historical Laboratory Control Data of the Negative Control (in 2014 - 2016) without S9 ( - S9)
TA 98 TA 100 TA 1535 TA 1537 TA 102
Mean 24.2 90.7 13.8 8.2 270.4
SD 6.7 15.6 6.7 2.9 55.0
Min 11 49 4 3 141
Max 58 155 41 35 472
RSD [%] 27.7 17.2 48.6 35.3 20.3
n 972 1191 929 931 682
Historical Laboratory Control Data of the Negative Control (in 2014 - 2016) with S9 ( - S9)
TA 98 TA 100 TA 1535 TA 1537 TA 102
Mean 29.0 96.4 10.5 8.3 339.7
SD 6.8 14.1 4.5 3.1 71.3
Min 15 62 3 3 157
Max 59 160 38 36 586
RSD [%] 23.4 14.6 42.7 37.4 21.0
n 967 1189 925 926 676
S9: metabolic activation
Conc.: concentration
Mean: mean of revertants/plate
Min.: minimum of revertants/plate
Max.: maximum of revertants/plate
SD: Standard Deviation
RSD: Relative Standard Deviation
n: Number of control values
NaN3: sodium azide
4-NOPD: 4-nitro-o-phenylene-diamine
MMS: methylmethanesulfonate
2-AA: 2-aminoanthracene - Conclusions:
- Ethyltriphenylfphosphonium iodide was not mutagenic (negative) in the reverse gene mutation assay in bacteria according to OECD guideline 471 (adopted 21 July 1997) and EU method B.14 (dated May 30, 2008) with Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and TA 102 with and without metabolic acitvation.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In a reverse gene mutation assay in bacteria according to OECD guideline 471 (adopted 21 July 1997) and EU method B.13/14 (dated May 30, 2008), Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and TA 102 were exposed to Ethyltriphenylphosphonium iodide in the absence and in the presence of mammalian metabolic activation (rat liver S9 mix). The assay was performed using the plate incorporation method (experiment I) and the preincubation method (experiment II). In the dose range finding test, performed as plate incorporation test, the test substance was tested formulated in DMSO up to concentrations of 5000 µg/plate in the absence and presence of S9-mix in the strains TA98 and TA100. In experiment I, concentrations up to 5000 µg/plate and in experiment II, concentrations up to 2500 µg/plate were tested in the absence and presence of S9-mix. Toxic effects of the test item were noted in all tester strains.
No biologically relevant increases in revertant colony numbers of any of the five tester strains were observed following treatment with Ethyltriphenylphosphonium iodide at any concentration level, neither in the presence nor absence of metabolic activation in experiment I and II.
Based on the results of this study it is concluded that Ethyltriphenylphosphonium iodide is not mutagenic in the bacterial reverse mutation assay.
Justification for classification or non-classification
Ethyltriphenylfphosphonium iodide is not mutagenic in the bacterial reverse mutation assay.
According to the criteria of REGULATION (EC) No 1272/2008, Ethyltriphenylphosphonium iodide does not have to be classified and has no obligatory labelling requirement for mutagenicity. According to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations (2004), Ethyltriphenylphosphonium iodide does not have to be classified for mutagenicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.